| SpectraBase Spectrum ID |
DozAgxaL1cG |
| Name |
DFMDMA PR |
| Classification |
Amphetamine designer drug derivative |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
271.138385180 u |
| Formula |
C14H19F2NO2 |
| InChI |
InChI=1S/C14H19F2NO2/c1-4-7-17(3)10(2)8-11-5-6-12-13(9-11)19-14(15,16)18-12/h5-6,9-10H,4,7-8H2,1-3H3 |
| InChIKey |
PEDOXKJQGBLPQX-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
271.308 g/mol |
| Nominal Mass |
271 u |
| Quality |
995 |
| Retention Index |
1501 |
| SMILES |
C=12C(OC(O2)(F)F)=CC(CC(N(CCC)C)C)=CC1 |
| SPLASH |
splash10-0udi-6900000000-97d041a86417e595d67d |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Amphetamine,N,N-methyl-propyl-(3,4-difluoromethylenedioxy)
N-Methyl-N-propyl-3,4-difluoromethylenedioxyamphetamine
N-(1-(2,2-difluoro-1,3-benzodioxol-5-yl)propan-2-yl)-N-methylpropan-1-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_019473 |
